» Articles » PMID: 27421135

Incidence and Origin of Histologically Confirmed Liver Metastases: an Explorative Case-study of 23,154 Patients

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Jul 16
PMID 27421135
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The liver is a common metastatic site for a large variety of primary tumors. For both patients with known and unknown primary tumors it is important to understand metastatic patterns to provide tailored therapies.

Objective: To perform a nationwide exploration of the origins of histological confirmed liver metastases.

Results: A total of 23,154 patients were identified. The majority of liver metastases were carcinomas (n=21,400; 92%) of which adenocarcinoma was the most frequent subtype (n=17,349; 75%). Most common primary tumors in patients with adenocarcinoma were from colorectal (n=8,004), pancreatic (n=1,755) or breast origin (n=1,415). In women of 50 years and younger, metastatic adenocarcinoma originated more frequently from breast cancer, while in women older than 70 years liver metastases originated more frequently from gastrointestinal tumors. Liver metastases in men older than 70 years originated often from squamous cell lung carcinoma. An unknown primary tumor was detected in 4,209 (18%) patients, although tumor type could be determined in 3,855 (92%) of them.

Methods: Data were collected using the nationwide network and registry of histo- and cytopathology in the Netherlands (PALGA). All histological confirmed liver metastases between January 2001 and December 2010 were evaluated for tumor type, origin of the primary tumor and were correlated with patient characteristics (age, gender).

Conclusion: The current study provides an overview of the origins of liver metastases in a series of 23,154 patients.

Citing Articles

Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).

Jin Z, Li Y, Yi H, Wang M, Wang C, Du S Int J Oncol. 2025; 66(3).

PMID: 39950314 PMC: 11844340. DOI: 10.3892/ijo.2025.5728.


Precision oncology: The role of minimally-invasive ablation therapy in the management of solid organ tumors.

Fazlollahi F, Makary M World J Radiol. 2025; 17(1):98618.

PMID: 39876886 PMC: 11755905. DOI: 10.4329/wjr.v17.i1.98618.


DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases.

Draskovic T, Rankovic B, Zidar N, Hauptman N Clin Epigenetics. 2024; 16(1):153.

PMID: 39497215 PMC: 11536859. DOI: 10.1186/s13148-024-01766-z.


Comprehensive Review of Future Liver Remnant (FLR) Assessment and Hypertrophy Techniques Before Major Hepatectomy: How to Assess and Manage the FLR.

Boubaddi M, Marichez A, Adam J, Lapuyade B, Debordeaux F, Tlili G Ann Surg Oncol. 2024; 31(13):9205-9220.

PMID: 39230854 DOI: 10.1245/s10434-024-16108-9.


Consideration on immunotherapy of liver metastases of malignant tumors.

Jiang C, Zhang Z, Li J World J Gastrointest Surg. 2024; 16(8):2374-2381.

PMID: 39220060 PMC: 11362915. DOI: 10.4240/wjgs.v16.i8.2374.


References
1.
Hugen N, van de Velde C, de Wilt J, Nagtegaal I . Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol. 2014; 25(3):651-657. PMC: 4433523. DOI: 10.1093/annonc/mdt591. View

2.
van de Wouw A, Janssen-Heijnen M, Coebergh J, Hillen H . Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer. 2002; 38(3):409-13. DOI: 10.1016/s0959-8049(01)00378-1. View

3.
diSibio G, French S . Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med. 2008; 132(6):931-9. DOI: 10.5858/2008-132-931-MPOCRF. View

4.
Pavlidis N, Fizazi K . Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol. 2008; 69(3):271-8. DOI: 10.1016/j.critrevonc.2008.09.005. View

5.
van Walsum G, de Ridder J, Verhoef C, Bosscha K, van Gulik T, Hesselink E . Resection of liver metastases in patients with breast cancer: survival and prognostic factors. Eur J Surg Oncol. 2012; 38(10):910-7. DOI: 10.1016/j.ejso.2012.04.015. View